4DMedical Limited (ASX:4DX) Reports 103% Revenue Growth and Strategic Milestones
4DMedical Limited (ASX:4DX) achieves 103% YTD revenue growth and secures key strategic partnerships in Q3 FY2025.

4DMedical Limited (ASX:4DX) achieves 103% YTD revenue growth and secures key strategic partnerships in Q3 FY2025.
Australian Rare Earths Limited (ASX:AR3) extends uranium mineralisation at Overland Project, supporting calcrete-hosted model with assay results expected soon.
Zelira Therapeutics (ASX:ZLD) enhances financial flexibility with a $1.15M R&D refund and a $1M ATM facility to support ongoing developments.
Rimfire Pacific Mining (ASX:RIM) announces successful Q1 scandium drilling at Murga and Currajong, and raises $3.65M in funding.
Odyssey Gold Limited (ASX:ODY) has launched a Technical Study to evaluate mining and processing options for its Tuckanarra Gold Project.
Immutep Limited (ASX:IMM) announces significant clinical trial milestones and maintains a robust cash position in its Q3 FY25 report.
Health and Plant Protein Group Limited (ASX:HPP) releases FY25 Q3 report, highlighting cash flow and ongoing IRS repayment efforts.
BrainChip Holdings Ltd (ASX:BRN) releases Q1 2025 report, highlighting key partnerships and a solid financial position.
G8 Education Limited (ASX:GEM) reports a 14.8% EBIT increase and highlights strategic initiatives during its 2025 AGM.
Donaco International (ASX:DNA) announces Q3 FY2025 results and a share acquisition Scheme Implementation Deed to strengthen its cash position.